The company provides scanning and reporting diagnostic services to NHS trusts and diagnostic hubs across the UK.
Priding itself on its speed and exceptional standards, the company has a large network of professionals that provide clinical in-sourcing services utilising NHS sites, machinery, and software, with works being completed to industry standards at BSE accredited level.
The company is now being offered for sale to facilitate growth under the impetus of new ownership.
Offers invited.
Key Highlights
• Provides vital and urgent scanning and reporting to NHS patients within a specialist, niche field.
• Benefits from relationships with a number of prestigious NHS trusts across the UK that provide ongoing repeat business on a weekly basis.
• Part of a national procurement framework for the provision of clinical insourcing.
• Works with a large team of industry professionals that carry out on-site diagnostic works.
• Fully relocatable opportunity.
• Benefits from a secure pipeline of ongoing contracts, with new tenders being released into the market continuously for clinical in-sourcing.
Financial Highlights
• Turnover of circa £700k in YE22, with an EBITDA of £250k.
• Forecasted turnover of £1.5m in YE23, with an EBITDA of circa £400k.
